Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$2.70
-6.75%
Mkt Cap $202.23M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+85.5%
Consensus $5.00 vs current $2.70
NASDAQ·Healthcare·Biotechnology
$2.70
-6.75%
Mkt Cap $202.23M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+85.5%
Consensus $5.00 vs current $2.70